After surgery for stage 2 lung cancer, one should actively choose adjuvant chemotherapy, and consider targeted therapy if it is sensitive to targeting.
Surgical resection of lung cancer is an important way, and after surgical resection, it should be decided whether adjuvant treatment is needed according to the pathological stage of the patients. For stage 2, adjuvant chemotherapy or targeted therapy should be chosen actively, which can improve the prognosis of patients and reduce the probability of recurrence and metastasis.
In recent years, targeted therapy has been able to achieve better therapeutic effect for some patients, and genetic testing is needed, and sensitive patients should be actively selected.
Adjuvant chemotherapy is needed for postoperative stage 2 lung cancer, and the need for targeted therapy should be evaluated according to the results of genetic testing.